Overall analysis showed that age, sex, laterality, tumor size, pathology type, bone destruction, nerve or perineural invasion, invasion of peripheral tissue, T stage, AR, Her-2, and treatment had no significant correlation with prognosis (P > 0.05), while the higher expression of Ki-67 may have higher risk of death or metastasis (P = 0.020) (Table 1). This evidence concerns the gene ERBB2 and neoplasm.